【EirGenix】February 2026 Revenue: NT$85M (YoY +100.6%)
EirGenix, Inc. has released its financial report for February 2026, posting a monthly revenue of NT$85 million, which represents a 100.6% growth compared to the same period last year. This figure indicates the biotechnology and medical care company's strong expansion in its CDMO business.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Company Code: 6589
Company Name: EirGenix, Inc.
Industry: Biotechnology and Medical Care
Data for: 2026-02
Monthly Revenue: 84,957 thousand NTD (0.85 hundred million)
Year-over-Year Change: +100.6%
Company Name: EirGenix, Inc.
Industry: Biotechnology and Medical Care
Data for: 2026-02
Monthly Revenue: 84,957 thousand NTD (0.85 hundred million)
Year-over-Year Change: +100.6%